A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects

Author:

Petrella Carla1,Farioli-Vecchioli Stefano2,Cisale Giusy Ylenia3,Strimpakos Georgios2,Borg John Joseph4,Ceccanti Mauro5,Fiore Marco1,Monteleone Giovanni6,Nisticò Robert7

Affiliation:

1. Institute of Biochemistry and Cell Biology, IBBC, CNR, Policlinico Umberto I, Rome, Italy

2. Institute of Biochemistry and Cell Biology, IBBC, CNR, Monterotondo, Rome, Italy

3. Department of Physiology and Pharmacology “V. Erspamer”, Sapienza University of Rome, Italy

4. Malta Medicines Authority, Malta Life Sciences Park, San Gwann SGN 3000, Malta; School of Pharmacy, University of Tor Vergata, Rome, Italy

5. Centro Riferimento Alcologico Regione Lazio, ASL ROMA 1, Rome, Italy

6. Department of Systems Medicine, University of Tor Vergata, Rome, Italy

7. Laboratory of Pharmacology of Synaptic Plasticity, Fondazione EBRI Rita Levi Montalcini, Rome, Italy

Abstract

: A large body of research has shown the presence of a complex pathway of communications between the gut and the brain. It is now recognized that, through this pathway, the microbiota can influence brain homeostasis and plasticity under normal and pathological conditions. : This review aims at providing an overview of preclinical and clinical pieces of evidence supporting the possible role of gut-brain axis modulation in physiological aging, in a neurodevelopmental disorder, the autism spectrum disorders and in a substance abuse disorder, the alcohol addiction. : Since the normalization of gut flora can prevent changes in the behavior, we postulate that the gutbrain axis might represent a possible target for pharmacological and dietary strategies aimed at improving not only intestinal but also mental health. The present review also reports some regulatory considerations regarding the use of probiotics, illustrating the most debated issues about the possibility of considering probiotics not only as a food supplement but also as a “full” medicinal product.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3